f j . • •
·.:~europass Curriculum vitae
INFORMAT1I PERSONALE Ana Maria Vladareanu (nascuta Gherasim)
9 str Mozart, nr 41 , Bucuresti, Romania, 051862 Bucuresti (Romania)
(Ii 40213180522/ 555
EXPERIENTA PROFESIONALA
01/03/2005-Prezent Sef Clinica - Clinica Hematologie Spitalul Universitar de Urgenta Bucuresti Spitalul Universita de Urgenta, Bucuresli (Romania)
25/0212008-Prezent Profesor Universitar in cadrul Universitatii de Medicina si Farmacie Carol Davila Bucuresti, Doctor in Medicina
EDUCA"f)E $1 FORMARE
Universitatiea de Medicina si Farmacie Carol Davila, Bucuresti
• Supraspecializare in Transplant Medular si de Celule Stem -Absolvit in lanuarie 2005
• Competenta in Management Sanitar - Absolvit in Octombrie 2004
• Competenta in Hematologie de Laborator -Absolvit in Decembrie 2004
• In 1997, Doctor in Medicina-Hematologie- Universitatea de Medicina si Farmacie "Carol Davila" Bucuresti cu lucrarea: Evaluarea factorilor prognostici in Limfoamele maligne Non -Hodgkiniene
• 1995 - 1996 - Bursa DAAD Ruprecht Karls Universitat Heidelberg Medizinische Klinic und Poliklinic V - Hamatologie, Onkologie and Rheumatologie - Heidelberg (sub supravegherea Prof Hunstein si R Haas)o 1982-1986 - Liceul de Matematica Fizica « Nicolae Balcescu » - Sfantul Sava - Bucuresti
• 1992 - curs in perioada studentiei : Departamentul de Pneumologie si Cardiologie, Royal British lnfirmery, Bristol, U.K.
• 1986 - 1992 - Facultatea de Medicina Generala Universitatea de Medicina si Farmacie "Carol Davila"- Bucuresti -Absolventa cu media 1 O - declarata sefa de promotie. Lucrare de diploma cu tema: Studiul tahiaritmiilor supraventriculare in infarctul acut de miocard
Liceul de Matematica Fizica « Nicolae Balcescu » - Sfantul Sava -Bucuresti
COMPETENTE PERSONAL.E
28/1/18 ro Uniunea Europeana. 2002-2017 I http://eurupass.cedefop.eurupa.eu Pagina 1 I 9
I ~uropass Curriculum vitae Ana Maria Vladareanu (nascuta Gherasim)
Limba(i) matema(e) Romana
Alte limbi straine cunoscute
Gennana
Engleza
Franceza
Competen\e organiza~onale/manageriale
Compelen\e dobandite la locul de munca
Competentele digitale
28/1/18
------ -----------, lNTELEGERE VORBIRE SCRIERE
. ____ Asculta_re _ __ j_ __ cl~-;-·- - Participare la ·~ -- _ conve~ e _ J_ ... ~,~~oral C2 -c2 __ _,____;:c;;:.;.;.;..:c =2 C_2 _____ C_2 __
Q Q Q Q ~
82 B2 82 82 B2 Niveluri: A 1 ~ A2.: Utilizator ~iemen~;~B1 ~-82: Utiffzalor Independent - C1 ~ C2: uiiriza~;xperimen1at Cadrul european oomua de IJ!ferialll oentru lmbl doe
Sef Clinica din 2005
Director al unui Grant National de Cercetare, responsabil stiintific / responsabil partener in 3 Granturi Nationale
Investigator Principal in 8 studii intemationale
Organizator de evenimente stiintifice (conferinte nationale, simpozioane, mese rotunde):
1. Masa rotunda cu tema ,Actualitati si perspective in tratamentul LGC", Bucuresti, 25.09.2009, organizata de Clinica Hematologie SUUB, UMF Carol Davila Bucuresti, Colegiul Medicilor din Romania. Manifestare acreditata cu puncte EMC
2. Masa rotunda cu tema ,Actualitati si perspective in limfoproliferarile cronice - translatia datelor stiintifice in practica dinica-", Bucuresti, 11 .12.2010, organizata de Clinica Hematologie SUUB, UMF Carol Davila Bucuresti
3. Actualitati in diagnostic si perspective in sindroamele mielodisplazice -abordare complexa; lnvitat special: Profesor Dr. Marie-Christine Bene, Nancy, Franta
organizata de Clinica Hematologie SUUB, UMF Carol Davila Bucuresti, 16 Septembrie 2011
Lider al Comitetului Stiintific si de Organizare a celei de-a doua Conferinta Nationala a Societatii Romane de Tromboza si Hemostaza (10-12. XI. 2011 , Bucuresti)
VicePresedinte al Societatii Romane de Tromboza si Hemostaza
Membru in board-ul Societatii Romane de Hematologie
Membru in comitetul medical si in comitetul de etica al Spitalului Univeristar de Urgenta Bucuresti
Membru in Consiliul de Conducere (din partea parintilor) Colegiul German Goethe Bucuresti (Goethe Deutches Kolleg Bukarest) - scoala oficiala a minoritatii germane in Bucuresti
Sef ctinica, coordonator al intregii echipe a Clinicii Hematologie SUUB (medici, personal mediu, personal inferior)
Aclivitatea Clinica - interactiunea zilnica cu pacientii - consulturi, decizii, etc
Activitatea didactica pentru studentii Medicina Generala, Medicina Dentara, Modul Limba Engleza, Facultatea de Asistente si Moase, Cursuri optionale.
Activitate didactica medici rezidenti (hematologie, medicina de laborator, medicina intema, nefrologie, geriatrie, etc) Conducator doctorate UMF Carol Davila Bucuresti
Procesarea informa~ei
Utilizator experimentat
Comunicare
Utilizator experimental
Competenteje djgjlaje . Grj~ ~ ;tWluare
AUTOEVALUARE
Crearede c:on~nut
Utilizator experimentat
rr,, Unitmea Europeanll, 2002-2017 I l1ttp://eumpass.cedefop.europa .eu
SeOJritate
Utilizator experimental
Rezolvarea de probleme
Utilizator experimental
Pagina 2 / 9
• ' I
-~ uropass Curriculum vitae Ana Maria Vladareanu (nascuta Gherasim)
Foarte bune competente de operare a calculatorului
Alte competen\e lanuarie 2005: Supraspecializare in Transplant Medular si de Celule Stem
Octombrie 2004: Competenta in Management Sanitar
Decembrie 2004: Competenta in Hematologie de Laborator
1996-1996: tehnica PCR - pentru virusul HIV
1996-1996: diagnostic hematologic de laborator (microscopie optica si imunofenotipare)
1996-1996: practica transplantului medular side celule stem hematopoietice pentru neoplazii hematologice si ne-hematologice
Permis de conducere B
INFORMATII SUPLIMENTARE
2P,/1/18
Adivitate ~tiin\ificll Autor a 5 monografil
5 monografii in calitate de autor
1. "Actuali~~ in limfoamele maligne non-Hoclgkiniene",
Ana-Maria VIMareanu,
33 capitole, 395 pagini, Editura Medicala Amaltea - octombrie 2002,
a primit Premiul Academiei Romane 'Victor Babef pe anul 2002, decemat in 2004.
2. Diagnosticul Hemopatiilor Maligne in note si imagini de atlas
Ana Maria Vladareanu
5 capitole , 380 pagini, Editura Universitara "Carol Davila" Bucuresti, decembrie 2007 ,
3. Limfoamele in Corelalie cu Virusurile Limfotrope
Ana Maria Vladareanu
6 sectiuni, 38 capitole., 256 pagini
Editura Medicala Amaltea decembrie 2007,
4. Patologia hematologica a femeii in perioada fertila
Ana Maria Vladareanu
22 capitole, 278 pagini: Editura lnfomedica decembrie 2007
Coautor al unei monografii: Tumorile intestinului subtire, autor: Dr. Costel Savlovschi,
Editura Medicala, 2009
Autor sau coautor a 33 capitole in tratate sau monografii in edituri medicale consacrate,
Autor sau coautor a peste 100 articole si studii publicate in reviste indexate in baze de date intemationale sau reviste medicale romanesti recunoscute CNCSIS, dintre care:
- 29 articole in extenso indexate Pubmed.
- 48 lucrari indexate ISi (articole in extenso, meeting abstracts, etc.)
Autor sau coautor a peste 100 de Cornunicari, Rapoarte Sesiuni Educationale, Prezentari Orale, Postere, abstracte acceptate/prezentate la conferinte, simpozioane, congrese, intemationale si nationale
Autor sau coautor a peste 200 studii raportate (abstracte / in extenso) publicate in volumele manifestfirilor ~tiintifice intema\ionale si na\ionale
ro Uniunea Europeantl. 2002-2017 I http://europass.cedefop.europa.eu Pagina 3 / 9
/ ~uroposs
Activitate de cercetare
Membru Structuri /Societati Stiintifice
28/1/18
Curriculum vitae Ana Maria Vladareanu (nascuta Gherasim)
• _Di~cto~ de G_rant CEEX MULTRO: Studiul complex al trombocitului in Sindroarnele Mieloproliferative SI Mtelodisplaz1ce, nr. 62/2005, 2005-2008
- re~ponsabil stiintific de proiect / reponsabil echipa de cercetare din partea SUUB in 3 Granturi nationale PNCDII:
· . LMCROM: " Monitorizarea moleculara a oncogenei hibrid BCR-ABL in leucemia mieloida cromca (LMC) pnn PCR real time cantitativ: fondarea registrului national pentru pacientii cu LMC". PNCD1 - 2006-2010/ protect condus de UMF Carol Davila -Conf. Dr. Daniel Coriu
· . ~IM_F~-VIR: "~orelarea metodelor de diagnostic privind evaluarea implicarii virusurilor ~ep~titice_ in hmfoproliferarile cronice - prevalenta infectiei si identificarea unor mecanisme moleculare 1mphcate In oncogeneza" - PNCD1 - 2006-2010/ proiect condus de Inst Matei Bals-Conf. Dr. Victoria Arama
· BAC-LC National Project : "Biomarkeri si agenti de chimiopreventie in limfoproliferarile cronice"" PNCD1- 2007-2011/ proiect condus de Inst De Virusologie Stefan Nicolau - Cercetator Dr. Viviana Roman
- Membru in colectiv Hematologia Coltea: ,.Patologia elementelor figurate ale singelui in bolile cardiovasculare" - Programul VIASAN - Sef de proiect Prof Dr. Delia Mut Popescu 2001- 2005
- Membru in colectiv Hematologia Coltea: ,,Diagnosticul precoce al limfoproliferarilor benigne, maligne side granita" -CNCSIS-Sef de proiect Prof Dr. Delia Mut Popescu 1995-1996
- Membru in colectiv Hematologia Collea: ,,Diagnosticul precoce al limfoproliferarilor de granita la tineri" -Academia de Stiinte Medicale. Prof Dr. Delia Mut Popescu 1997.
- Investigator principal / responsabil stiintific - lider al echipei de cercetare Hematologie UMF Carol Davila Bucuresti- SUUB- Romania in programul EUTOS (incepand din 2009, in desfasurare) sub coordonarea European Leukemia Net
- Participari in Comisii Exteme si lnteme - Granturi de Cercetare membru in echipa de avizare extema a 4 granturi CEEX, si a unui grant VIASAN
Studii: Investigator Principal in 8 studii intemationale multicentrice
-DAC0-016: Randomized Phase 3 Trial of Decitabine Versus Patient's Choice with Physician's Advice of Either Supportive Care or Low-dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia
MGI Pharma - 2005 - 2009
-TRA 100773 Phase Forward Study-Adouble blind, randomized, placebo-controlled, parallel group study to investigate the efficacy, safety, tolerability, pharmacokinetics and phannacodynamics of SB-497115-GR, a thrombopoietin receptor agonist in Refractory ITP.
GlaxoSmithKlinePhanna - 2005 - 2006
- Extend (Eltrornbopag extended dosing study) Randomized Phase 2 Trial ofTRA105325 in Refractory ITP
GlaxoSmithKlinePhanna - 2006- 2009
-OMB 110913: A Phase 111, Open Label, Randomized Trial ofOfatumumabAdded to FludarabineCyclophosphamide vs. Fludarabine-Cyclophosphamide Combination in Subjects with Relapsed Chronic Lymphocytic Leukemia
GlaxoSmithKlinePharma, faza de recrutare a pacientilor - inceput in 2011
- Protocol 20130109: A Randomized, Double-blind Study Evaluating the Efficacy, Safety and lmrnunogenicity of ABP 798 Compared with Rituximab in Subjects with CD20 Positive B-cell nonHodgkin Lymphoma (NHL)
AMGEN, faza de recrutare - inceput in 2016
Membru Structuri /Societatl Stlintifice Natlonale si Internationale
Membru al Myeloma Euronet Romania - (din 2006)
Membru al Societatii Europene de Hematologie (din 1996)
Membru al Societatii Balcanice de Hematologie (de la infiintarea sa din 2005)
Membru al Societatii Romane de Flowcytometrie (de la infiintarea sa din 2005)
Vicepresedinte si Membru Fondator al Societatii Romane de Hemostaza si Tromboza (din Mai 2007)
ro Uniunea Europeani\. 2002-2017 I http://europass.cedefop.europa.eu Pagina 4 / 9
I ~ uropass Curriculum vitae
Ana Maria VIMareanu (nascu~ Gherasim)
Membru al Societalii Romana de Hematologie (din 1993)
Membru al Societatii Europene de Oncologie pe perioada limitata (1998-2000)
Membru al Societatii Internationale de Hematologie pe perioada limitata (1998-2000)
· Membru Leukemia-Net - din partea Universitatii de Medicina si Farmacie Carol Davila Bucuresti
· Membru in multe Asociatii Nationale si Grupuri de Lucru in Hematologie in Romania (Grupul de L~cru pentru Leucemie Granulocitara Cronica, Grupul de Lucru pentru LLC, Grupul de Lucru pentru Llmfoame, lnfectiile fungice in practica hematologica) si al Grupul de Lucru pemtru conceperea Ghidurilor practice in Obstetrica - Ginecologle
Member In the Board of the Romanian Society of Hematology
Senll Comisiei de Boli Rare din cadrul Ministerului Sanatatii
Membru EUCERD ( European Union Comission Experts for Rare Diseases) - reprezentatul Romaniei pentru Boli Rare
Lider al Comisiei Boli Rare din cadrul UMF Carol Davila Bucuresti
Membru al Comisiei Oncologie- Casa de Asiguraria Municipiului Bucuresti
Membru Grupuri de Lucruri - in cadrul Societatii Romane de Hematologie, privind terapiile tintite in praclica clinica, conform protocoalelor Casei de Asigurari
Lider al grupului de lucru UMF Carol Davila in cadrul ELN- European Leukemia Net - WP6, WP7, WP10
Membru in Colective Editoriale/ Membru in 5 colective editoriale/ de redactie reviste CNCSIS: Revista de Medicina lntema, Mernbru Peer Review lnfomedica, Revista Romana de Tromboza si Hemostaza, Documenta Hematologica, Practica
Medicala
Referent la lnfomedica si la Maedica
Editor Sef- University Journal of Hemostasis and Thrombosis (2011)
Premii -Premiu acordat de Award Committee for the 15TH 2011 Developing World Scientist Grants: The risk of stroke and myocardial infarction in patients with myeloproliferative neoplasms. A study of the importance of platelet aggregation. Viola Maria Popov, Ana Maria Vladareanu, Horia Bumbea, Eugenia Kovacs, Tudor Savopol, Adrian Tase, Minodora Onisai, Mihaela Camelia Stancu, Anca Maria Ilea, Camelia Dobrea. XXIII Congress of the ISTH, July 23-28, 2011 in Kyoto, Japan
Congress Abstract CD-ROM, as a supplement to Journal of Thrombosis and Haemostasis
-Premiul special pentru colaborarea cu Societatea Romana de Medicina lntema - decembrie 2009
-Premiul Universitatii Carol Davila Bucuresti pentru monografia ,,Diagnosticul Hemopatiilor Maligne in note si imagini de atlas", Ana-Maria Vladareanu, in cadrul Zilelor Universilare Carol Davila, 6 nov 2008
-Premiu pentru cea mal buna lucrare publicata in Revista Medicina lntema in anul 2008, pentru lucrarea: Defects in platelet surface antigens in Chronic Myeloproliferative Syndrome identified by flow cytornetry analysis. Horia Bumbea, Ana-Maria Vladareanu, Sinziana Radesi, Veronica Vasilache, Cristina Ciufu, Anca Petre, Diana Cisleanu, Madalina Begu, Irina Voican, Cristina Marinescu, Viola Popov*, Minodora Onisai, Mihaela Dervesteanu. Medicina lntema Nr. 1/2008 Volumul VI/Serie noua
-Premiul Academiel Romane: Victor Babes 21 XII 2004: pentru monografia "Actualitati in Limfoarnele Maligne Non-Hodgkiniene", Ana-Maria Vladareanu
-Prernii pentru lucrari la congrese naponale: 2
Anexa 1. - Cele mai Cele mai reprezentative articole in extenso indexate ISi: reprezentative articole in extenso
indexate ISi: 1. Assessment of changes in membrane properties of platelets from patients with chronic myeloid leukaemia in different stages of the disease
Popov, Viola M.; Vladareanu, Ana M.; Burnbea, Horia; et al.
BLOOD COAGULATION & FIBRINOLYSIS Volume: 25 Issue: 2 Pages: 142-150 Published: MAR2014
28/1/18 ro Uniunea Europeana. 2002-2017 I http://europass.cedefop.europa.eu Pagina 5 / 9
/ ~ uropass
28/1/18
Curriculum vitae Ana Maria Vladareanu (nascuta Gherasim)
~YELo~\Ss~~OIA~~SFOCHYPERTHYROIDISM DURING IMMUNOTHERAPY IN Mu IATED WITH GRAVES' DISEASE
By: Bumbea, H. ; Badiu, C.; Dobrescu, R.; et al.
~~~~~~~~: INOLOGICA-BUCHAREST Volume: 9 Issue: 2 Pages: 289-294 Published:
3. HEPARIN INDUCED THROMBOCYTOPENIA: A REVIEW
By: Voican, Irina; Onisai, Minodora; Nicolescu, Anca; et al.
FARMACIA Volume: 60 Issue: 6 Pages: 773-784 Published: NOV-DEC 2012
4. Perinatal outcome for pregnancies complicated with thrombocytopenia
By: Onisai, Minodora; Vladareanu, Ana-Maria; Delcea, Caterina; et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE Volume: 25 Issue: 9 Pages: 1622-1626 Published:SEP 2012
5. . Refractory anemia with ring sideroblasts associated with marked thrombocytosis: case report and literature review
By: Gaman, Mihaela; Vladareanu, Ana-Maria; Onisai, Minodora
ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY Volume: 53 Issue: 3 Pages: 645-650 Published:2012
6. lmmunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 1 O
By: Bene, M. C.; Nebe, T.; Bettelheim, P.; et al.
LEUKEMIA Volume: 25 Issue: 4 Pages: 567-574 Published: APR 2011
7. Molecular markers guide diagnosis and treatment in Philadelphia chromosome-negative myeloproliferative disorders
By: Vladareanu, Ana Maria; Mueller-Tidow, Carsten; Bumbea, Horia; et al.
ONCOLOGY REPORTS Volume: 23 Issue: 3 Pages: 595-604 Published: MAR 2010
8. Is There a Role for Platelet Flowcytometry in the Diagnosis of Severe Thrombocytopenia in Pregnancy?
By: Onisai, Minodora; Vladareanu, Ana-Maria; Bumbea, Horia; et al.
GINECO RO Volume: 6 Issue: 2 Pages: 128-133 Published: 2010
Cele mai reprezentative articole in extenso indexate Pubmed si in alte baze de date intemationale.
1. Primary myeloflbrosis and pregnancy outcomes after row morecurar-wejght bepadn administration: A case reoort and literature ceYiew Bohiftea RE, Cirstolu MM, Ionescu CA, Niculescu-Mizil E, Vladareanu AM, Voican I, Dimitriu M, TurcanN.
Medicine (Baltimore). 2017 Nov;96(46):e8735. doi: 10.1097/MD.0000000000008735. Review.
2. MECQM HBS1 L-MYB THRB-RARB JAK2 and JERI ootymomhisms defining the genetic predisposition to myelopeolifecatiye neoplasms· A study on 939 patients Trifa AP, Banescu C, Bojan AS, Voina CM, Popa$. Vi~n S, Ciubean AD, Tripon F, Dima D, Popov VM, Vesa $C, Andreescu M, T6r6k-Vistai T, Mihaila RG, Berbec N, Macarie I, Co(ita A, lordache M, Catana AC, Farcal;i MF, Tomuleasa C, Vasile K, Truica C, Todinca A. Pop-Muntean L, Manolache R, Bumbea H, Vladareanu AM, Gaman M, Ciufu CM, Popp RA.
Am J Hematol. 2018 Jan:93(1):100-106. doi: 10.1002/ajh.24946. Epub 2017 Nov 10.
3. TERI rs27361 oo A>C SNP and JAK2 46/1 haprotype sjgnificantty contribute to the occurrence ofJAK2 V61ZE and CALR mutated myeroprorjferatjye oeoprasms - a multjcentric study on 529 patients. Trifa AP, Banescu C, Tevet M, Bojan A, Dima D, Urian L, T6r6k-Vistai T, Popov VM, Zdrenghea M, Petrov L, Vasilache A, Murat M, Georgescu D. Popescu M, Patrinoiu 0 , Balea M, Costache R, Colel;i E, $aguna C, Berbec N, Vladareanu AM, Mihai~ RG, Bumbea H, Cucuianu A. Popp RA.
Br J Haematol. 2016 Jul;174(2):218-26. doi: 10.1111/bjh.14041 . Epub 2016 Apr 7.
~ Uniunea European:\. 2002-2017 I http://europass.cedefop.europa.e<.1 Pagina 6 / 9
! ~ uropass
28/1/18
Curriculum vitae Ana Maria VIM~reanu (n~scu~ Gherasim)
4. 2016 \MjO Cljnjcal Molecular d p th 1 · MyelopmHferatjye N8Qpla<MPN ana O oglcal cqteria for ~lasslfication and staging of Genes ;0 the context sms > Caused by M\N Paver Mutations in the JAK2 MPL and CALR
. . --- of New 2016 WHO Classification- Prognostic and Therapeutic lmpHcatlons ~ichiels JJ, Tevet M, "!rif~ A, Nlculescu-Mlzil E, Lupu A, Vladareanu AM, Bumbea H, Ilea A, Dobrea
P, Georgescu D, Patrino1u 0 , Popescu M, Murat M, Dragan C, Mlhai F, Zurac s, Angelescu s, lova A. opa A. Gogulescu R, Popov V.
Maedica (Buchar). 2016 Mar:11(1):5-25. 5· ~te L,vmphoblastic Leukemia after previously treated relapsed Chron;c Lymphocytic Leukemia· Acase Report, Andrus E, Nlcolescu A, Bumbea H, Vli!idi!ireanu AM.
Rom J Intern Med. 2015 Apr-Jun:53(2):184-8.
6· Early severe preedamps;a wjtt, marked platelet dysfunction in association wtth essential thmmbocylemja· case report and djscuss;on Onisai M, Voican I, Ciorascu M, PopovV, Bumbea H, Gaman M, Filipescu A, Vladareanu R, Vladareanu AM.
Blood Coagul Fibrinolysis. 2015 Oct;26(7):830-3. doi: 10.1097/MBC.0000000000000352.
7. Acute L,vmphocytic Leukemia in AduHs Pathologic Features and Prognosis Marinescu C, Vli!idi!ireanu AM, Mihai F.
Rom J Intern Med. 2015 Jan-Mar,53(1):31-6. Review.
a. Diagnostic difficulties in acute royeloid (eukemja Enache TC, Vladareanu AM, Begu M, Bumbea H, Marinescu C, Dobrea C.
Rom J Intern Med. 2014 Oct-Dec;52(4):279-83.
9. Peripheral I and NK ceu no□:hodgkjn lymphoma a challenge for diagnosis Vasile D, Vladareanu AM, Bumbea H.
Maedica (Buchar). 2014 Mar,9(1):104-8. Review.
10. Therapeutic Options for Immune Thrombocytopenia (ITP) During Pregnancy.
Nicolescu A, Vladareanu AW'. , Voican I, Onisai M, Vladareanu R.
Maedica (Buchar). 2013 Jun;8(2):182-188. Review.
11 . Assessment of changes in membrane properties of platelets from patients with chronic myeloid leukaemia in different stages of the disease.
Popov VM, Vladareanu AM, Bumbea H, Kovacs E, Moisescu MG, Onisai M, lordache MM, Savopol T. Blood Coagul Fibrinolysis. 2014 Mar;25(2):142-50. doi: 10.1097/MBC.0b013e328365776f.
12. CML patients in the molecular era - report of five years experience of diagnosis and treatment in a single center.
Voican I, Vladareanu AM, Bumbea H, Barsan L, Vasile D.
J Med Life. 2013 Sep 15;6(3):319-26. Epub 2013 Sep 25.
13. Difficulty in classifying a B cell chronic lymphoproliferative disorder CD5+.
lova A. Vladareanu AM, Vasile D, Bumbea H.
Rom J Intern Med. 2012 Oct-Oec;50(4):309-12.
14. Sudden blast crisis in a chronic myeloid leukemia patient during imatinib therapy.
Voican I, Vli!idi!ireanu AM, Bumbea H, Begu M.
Rom J Intern Med. 2012 Jul-Sep;50(3):241-4.
15. Refractory anemia with ring sideroblasts associated with marked thrombocytosis: case report and literature review.
Gi!iman M, Vli!idi!ireanu AM, Onisai M.
Rom J Morphol Embryo!. 2012;53(3):645-50. Review.
16. The lymphocyte immunophenotyplcal pattern in chronic lymphocytic leukemia associated with hepatitis viral infections.
Bumbea H, Vladareanu AM, Vintilescu A, Radesi S, Ciufu C, Onisai M, Baluta C, Begu M, Dobrea C,
r() Unlunea Europeanll. 2002-2017 I http://eumpass.cedefop.europa .eu Pagina 7 / 9
! ~uroposs
28/1/1B
Curriculum vitae
Arama V, StreinLI-Cercel A, Ara J M mas.
eel Life. 2011 Aug 15;4(3):256-63 E 17 Do ble · pub 2011 Aug 25.
Ana Maria Vladareanu (nascuta Gherasim)
C . u transformation of a hemato . . . ase presentation and review of the literapot ietic malignancy and severe associated thrombopathy.
c· le ure. ~ anu D, OnisAi M, Vladareanu AM
Cazaceanu 0 , Begu M. Ilea A . Gaman M, Neagul AM, Bumbea H, lova A, Baluta C,
Rom J Intern Med. 2011 ;49(2):137-44. Review. 18, Perinatal outcom i 0
. . e or pregnancies complicated with thrombocytopenia rnsa, M, Wdareanu AM □el c c· ·
Rotaru o, VIMAreanu R. · cea · ,orascu M, Bumbea H, Nicolescu A, Voican I. Filipescu A.
J Matern Fetal Neonatal Med 2012 s 2012 Feb 14. · ep;2S(9):1622-6. doi: 10.3109/14767058.2011 .648245. Epub
19 · Platelet dysfunctio~ in acute leukemias and myelodysplastic syndromes.
VIAdareanu AM, Vasilache V. Bumbea H, OnisAi M.
Rom J Intern Med. 2011:49(1):93-6.
20. Reactivation of HBV infection in low grade lymphoma patient
Arama V. Mun~nu D, Olaru I, Radulescu M, Mihailescu R, Vladareanu AM, Onisai M, Vintilescu A, Dobrea C, Olanu M, Arama SS.
Rom J Intern Med. 2011;49(1):67-73.
21 . The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
Gaman M, Vladareanu AM, Radesi s. Rom J Intern Med. 2011 ;49(1):25-30. Review.
22. Pathogenesis of thrombotic and hemorrhagic complications in myeloproliferative and myelodysplastic syndromes
Vladareanu AM, Popov V. Bumbea H, Ciufu C, Vasilache V, Petre A, Onisai M.
Rev Med Chir Soc Med Nat lasi. 2011 Jan-Mar,115(1):14-9. Romanian.
23. Splanchnic vein thrombosis, the onset manifestation in JAK positive Chronic Myeloproliferative Disorders Neoplasms.
Vladareanu AM, Popov V, Bumbea H, Onisai M, Ilea A, Dobrea C, Miulescu M.
J Med Life. 2011 Jan-Mar,4(1):97-101. Epub 2011 Feb 25.
24. lmmunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Woix Package 10.
Bene MC, Nebe T, Bettelheim P, Buldini B, Bumbea H, Kem W, Lacombe F, Lemez P, Marinov I, Matutes E, Maynadie M, Oelschlagel U, Orfao A. Schabath R, Solenthaler M, Tschurtschenthaler G, Vladareanu AM, Zini G, Faure GC, PorwitA.
Leukemia. 2011 Apr,25(4):567-74. doi: 10.1038/leu.2010.312. Epub 2011 Jan 21 . Review.
25. Chronic myeloid leukemia-from the National to the European Registry-limited experience of a single center. Vladareanu AM, Voican I, Bumbea H, Vasile D, Radesi S, Coriu D, Colita A, TAmaci R, Ilea A.
26. .Chronic myeloid leukemia therapy in the era of tyrosine kinase inhibitors-the first molecular targeted treatment
Bumbea H, Vladareanu AM, Voican I, Cisleanu D, Barsan L, Onisai M.
J Med Life. 2010Apr-Jun;3(2):162-6. Review.
27. The impact of hepatitis viruses on chronic lymphoproliferative disorders-preliminary results.
Vladareanu AM. Ciufu C, Neagu AM, Onisai M, Bumbea H, Vintilescu AM, Dobrea C, Arama V. Mihailescu R, Arama S.
J Med Life. 2010 Jul-Sep:3(3):320-9.
28. Molecular markers guide diagnosis and treatment in Philadelphia chromosome-negative myeloproliferative disorders (Review).
Vladareanu AM, M0ller-Tldow C, Bumbea H, Radesi S.
Oneal Rep. 2010 Mar.23(3):595-604. Review.
~ Uniunea European:.. 2002-2017 I http://europass.cedefop.europa .eu Pagina 8 / 9
~uropass
28/1/18
Curriculum vitae
Ana Maria Vladareanu (nascuta Gherasim)
29. Splenectomy-a thera ti . . . Vlactarea AM . . peu c option in splenrc marginal zone cell lymphoma
. nu ' Onrsa1 M, Ciufu C Bu be H . Vintilescu A. Baluta C, Dobrea C Savio m a_ , Ci~leanu D, Voican I, Nicolescu A. Racle~i s, 2009;47(2):191-9. ' vschi C, Grecu L, Serban D, Serafm G. Rom J Intern Med.
3o. Preliminary data on the involve of . . . . chronic lymphoproliferative syndrom m~nt B, ~ and D hepatitis viruses In the etiopathogenesis of
es In Romania. Molagic v, Arama V Cerce! AS lri N C, Costoiu s Ma ' M ' mescu : Wdareanu AM, Olariu M, Arama SS, Rafila A, Dobrea Mihailescu R. rza , otelea D, Parasch1v S, Maxim D, Popa M, Bumbea H, Ciufu c, Baicu~ C,
Rom J Intern Meet. 2009;47(1):25-34.
31 . Ari update on the platelet dysfunction in chronic myeloproliferative syndromes.
Vladareanu AM, Ciufu C, Bumbea H, Onisai M, Arama s. Rom J Intern Med. 2008;46(1):9-15. Review.
32. Cryptic genomic abnormalities associated with coexpression of KOR-SA3544 and NG.2 in proB acute lymphoblastic leukemia.
Bumbea H, Serghei L, Vladareanu AM, Stefan LM, Casleanu D, Voican I, Begu M.
Rom J Intern Meet. 2007;45(4):387-91 .
33. Myeloma cells with asurophilic granules-an unusual morphological variant-case presentation.
Vladareanu AM, Ci~leanu D, Derve~teanu M, Onisai M, Bumbea H, Rade~i S, Begu M, Cristina B.
J Med Life. 2008 Jan-Mar,1(1):74-86.
34. Lymphoma immunophenotyping: "borderline" lymphomas.
Mut-Popescu D, Lupu A, Bumbea H, Vladareanu AM, Barbu D, Angelescu S, Olteanu N, Colita A
J Cell Mol Med. 2000 Jul-Sep;4(3):207-214.
© Uniunea European~. 2002-2017 I http://europass.cedefop.europa .eu Pagina 9 / 9
-